291 related articles for article (PubMed ID: 9820172)
21. Laser scanning cytometry evaluation of MART-1, gp100, and HLA-A2 expression in melanoma metastases.
Mocellin S; Fetsch P; Abati A; Phan GQ; Wang E; Provenzano M; Stroncek D; Rosenberg SA; Marincola FM
J Immunother; 2001; 24(6):447-58. PubMed ID: 11759068
[TBL] [Abstract][Full Text] [Related]
22. Expression of melanoma-associated antigens in melanoma cell cultures.
Urosevic M; Braun B; Willers J; Burg G; Dummer R
Exp Dermatol; 2005 Jul; 14(7):491-7. PubMed ID: 15946236
[TBL] [Abstract][Full Text] [Related]
23. HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients.
Reynolds SR; Celis E; Sette A; Oratz R; Shapiro RL; Johnston D; Fotino M; Bystryn JC
J Immunol; 1998 Dec; 161(12):6970-6. PubMed ID: 9862732
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of MART-1 in primary and metastatic melanoma lesions.
Kageshita T; Kawakami Y; Hirai S; Ono T
J Immunother; 1997 Nov; 20(6):460-5. PubMed ID: 9409451
[TBL] [Abstract][Full Text] [Related]
25. Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression.
Khong HT; Wang QJ; Rosenberg SA
J Immunother; 2004; 27(3):184-90. PubMed ID: 15076135
[TBL] [Abstract][Full Text] [Related]
26. Malignant melanoma with paradoxical maturation.
Ruhoy SM; Prieto VG; Eliason SL; Grichnik JM; Burchette JL; Shea CR
Am J Surg Pathol; 2000 Dec; 24(12):1600-14. PubMed ID: 11117780
[TBL] [Abstract][Full Text] [Related]
27. Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas.
Takeuchi H; Kuo C; Morton DL; Wang HJ; Hoon DS
Cancer Res; 2003 Jan; 63(2):441-8. PubMed ID: 12543800
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled--polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma.
Brownbridge GG; Gold J; Edward M; MacKie RM
Br J Dermatol; 2001 Feb; 144(2):279-87. PubMed ID: 11251559
[TBL] [Abstract][Full Text] [Related]
29. Expression of gp100 in melanoma metastases resected before or after treatment with IFN alpha and IL-2.
Scheibenbogen C; Weyers I; Ruiter D; Willhauck M; Bittinger A; Keilholz U
J Immunother Emphasis Tumor Immunol; 1996 Sep; 19(5):375-80. PubMed ID: 8941877
[TBL] [Abstract][Full Text] [Related]
30. Analysis of HLA class I expression in different metastases from two melanoma patients undergoing peptide immunotherapy.
Mendez R; Serrano A; Jäger E; Maleno I; Ruiz-Cabello F; Knuth A; Garrido F
Tissue Antigens; 2001 Jun; 57(6):508-19. PubMed ID: 11556981
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo.
Cormier JN; Hijazi YM; Abati A; Fetsch P; Bettinotti M; Steinberg SM; Rosenberg SA; Marincola FM
Int J Cancer; 1998 Feb; 75(4):517-24. PubMed ID: 9466650
[TBL] [Abstract][Full Text] [Related]
32. Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens.
Rosenberg SA; Zhai Y; Yang JC; Schwartzentruber DJ; Hwu P; Marincola FM; Topalian SL; Restifo NP; Seipp CA; Einhorn JH; Roberts B; White DE
J Natl Cancer Inst; 1998 Dec; 90(24):1894-900. PubMed ID: 9862627
[TBL] [Abstract][Full Text] [Related]
33. Cytolytic T cell reactivity against melanoma-associated differentiation antigens in peripheral blood of melanoma patients and healthy individuals.
Jäger E; Ringhoffer M; Arand M; Karbach J; Jäger D; Ilsemann C; Hagedorn M; Oesch F; Knuth A
Melanoma Res; 1996 Dec; 6(6):419-25. PubMed ID: 9013479
[TBL] [Abstract][Full Text] [Related]
34. Immunophenotypic differences between uveal and cutaneous melanomas.
Iwamoto S; Burrows RC; Kalina RE; George D; Boehm M; Bothwell MA; Schmidt R
Arch Ophthalmol; 2002 Apr; 120(4):466-70. PubMed ID: 11934320
[TBL] [Abstract][Full Text] [Related]
35. RT-PCR detection of tyrosinase, gp100, MART1/Melan-A, and TRP-2 gene transcripts in peripheral blood of melanoma patients.
Samija M; Juretić A; Solarić M; Samija I; Bingulac-Popović J; Grahovac B; Stanec M; Oresić V
Croat Med J; 2001 Aug; 42(4):478-83. PubMed ID: 11471202
[TBL] [Abstract][Full Text] [Related]
36. Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells.
Klarquist J; Barfuss A; Kandala S; Reust MJ; Braun RK; Hu J; Dilling DF; McKee MD; Boissy RE; Love RB; Nishimura MI; Le Poole IC
Am J Pathol; 2009 Dec; 175(6):2463-72. PubMed ID: 19893037
[TBL] [Abstract][Full Text] [Related]
37. Cloning, expression and tissue distribution of the murine homologue of the melanocyte lineage-specific antigen gp100.
Schreurs MW; de Boer AJ; Schmidt A; Figdor CG; Adema GJ
Melanoma Res; 1997 Dec; 7(6):463-70. PubMed ID: 9464618
[TBL] [Abstract][Full Text] [Related]
38. Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens.
van Dinten LC; Pul N; van Nieuwpoort AF; Out CJ; Jager MJ; van den Elsen PJ
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):24-30. PubMed ID: 15623750
[TBL] [Abstract][Full Text] [Related]
39. Melanoma antigen expression in serial fine-needle aspiration samples in patients with metastatic malignant melanoma participating in immunotherapy clinical trials: a preliminary look.
Fetsch PA; Steinberg SM; Riker AI; Marincola FM; Abati A
Cancer; 2001 Dec; 93(6):409-14. PubMed ID: 11748581
[TBL] [Abstract][Full Text] [Related]
40. Patterns of the immunohistochemical expression of melanoma-associated antigens and density of CD45R0+ activated T lymphocytes and L1-protein positive macrophages in primary cutaneous melanomas.
Piérard-Franchimont C; Letawe C; Nikkels AF; Piérard GE
Int J Mol Med; 1998 Dec; 2(6):721-4. PubMed ID: 9850742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]